|
|
Medical research has come a long way in the last hundred years, yet there are still many diseases for which there are no effective treatments.
That's why GlaxoSmithKline is committed to discovering and developing new medicines and vaccines. Being a large company, we can truly make a difference because we can devote vast resources to discover and develop new medicines and vaccines to improve the health of Australians. GSK has more than 20 research and development (R&D) facilities around the world, with an annual R&D budget of around $7 billion and more than 16,000 people employed in R&D. GSK's significant R&D infrastructure in Australia means that most GSK products available in Australia have also been researched here. GSK is a significant contributor to total industry spend on R&D, with investments of up to $35million each year in Australian research & development - ranking us in Australia’s top-10 R&D companies.*
*Source: Australia’s 2005 R&D and Intellectual Property Scoreboard.
 |
GlaxoSmithKline Medicines Research Unit
The GlaxoSmithKline Medicines Research Unit is a dedicated Clinical Pharmacology Unit situated in Sydney, Australia.
Through close collaboration with key opinion leaders, patient studies have been initiated and coordinated in Sydney and throughout Australasia.
|
|
 |
GSKA Post graduate support grants
In 2005 GSK Australia launched a support grant programme for postgraduate studies in the field of human health. These awards were designed to provide further financial support to PhD or other post graduate research students who are already in receipt of a research grant from a non commercial body.
|
|
 |
Research Excellence Award
Our GlaxoSmithKline Australia Award for Research Excellence is one of the most prestigious awards in the Australian R&D community. It carries a $50,000 grant and has been awarded annually since 1980 in recognition of outstanding medical research.
|
|
 |
|
